rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2011-5-25
|
pubmed:abstractText |
A prospective, phase III randomized study was undertaken to compare the outcomes of 2 different radiotherapy and chemotherapy sequences in conservatively treated patients with breast cancer.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1537-453X
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
34
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
238-44
|
pubmed:meshHeading |
pubmed-meshheading:20805741-Adult,
pubmed-meshheading:20805741-Aged,
pubmed-meshheading:20805741-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:20805741-Breast Neoplasms,
pubmed-meshheading:20805741-Chemotherapy, Adjuvant,
pubmed-meshheading:20805741-Cyclophosphamide,
pubmed-meshheading:20805741-Disease-Free Survival,
pubmed-meshheading:20805741-Drug Administration Schedule,
pubmed-meshheading:20805741-Female,
pubmed-meshheading:20805741-Fluorouracil,
pubmed-meshheading:20805741-Follow-Up Studies,
pubmed-meshheading:20805741-Humans,
pubmed-meshheading:20805741-Methotrexate,
pubmed-meshheading:20805741-Middle Aged,
pubmed-meshheading:20805741-Predictive Value of Tests,
pubmed-meshheading:20805741-Prognosis,
pubmed-meshheading:20805741-Prospective Studies,
pubmed-meshheading:20805741-Radiotherapy, Adjuvant,
pubmed-meshheading:20805741-Recurrence,
pubmed-meshheading:20805741-Risk Assessment,
pubmed-meshheading:20805741-Risk Factors,
pubmed-meshheading:20805741-Survival Analysis,
pubmed-meshheading:20805741-Time Factors,
pubmed-meshheading:20805741-Treatment Outcome
|
pubmed:year |
2011
|
pubmed:articleTitle |
Long-term results of a randomized trial on the sequencing of radiotherapy and chemotherapy in breast cancer.
|
pubmed:affiliation |
Department of Radiotherapy, Regina Elena National Cancer Institute, Rome, Italy.
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Clinical Trial, Phase III
|